Your browser doesn't support javascript.
loading
LGR5 promotes tumorigenicity and invasion of glioblastoma stem-like cells and is a potential therapeutic target for a subset of glioblastoma patients.
Xie, Yuan; Sundström, Anders; Maturi, Naga P; Tan, E-Jean; Marinescu, Voichita D; Jarvius, Malin; Tirfing, Malin; Jin, Chuan; Chen, Lei; Essand, Magnus; Swartling, Fredrik J; Nelander, Sven; Jiang, Yiwen; Uhrbom, Lene.
Afiliação
  • Xie Y; Department of Immunology, Genetics and Pathology, Uppsala University and Science for Life Laboratory, Rudbeck Laboratory, Uppsala, Sweden.
  • Sundström A; Department of Immunology, Genetics and Pathology, Uppsala University and Science for Life Laboratory, Rudbeck Laboratory, Uppsala, Sweden.
  • Maturi NP; Department of Immunology, Genetics and Pathology, Uppsala University and Science for Life Laboratory, Rudbeck Laboratory, Uppsala, Sweden.
  • Tan EJ; Department of Immunology, Genetics and Pathology, Uppsala University and Science for Life Laboratory, Rudbeck Laboratory, Uppsala, Sweden.
  • Marinescu VD; Department of Immunology, Genetics and Pathology, Uppsala University and Science for Life Laboratory, Rudbeck Laboratory, Uppsala, Sweden.
  • Jarvius M; Department of Medical Biochemistry and Microbiology, Biomedical Centre, Uppsala University and Science for Life Laboratory, Uppsala, Sweden.
  • Tirfing M; Department of Medical Sciences, Cancer Pharmacology and Computational Medicine, Uppsala University and Science for Life Laboratory, Uppsala, Sweden.
  • Jin C; Department of Immunology, Genetics and Pathology, Uppsala University and Science for Life Laboratory, Rudbeck Laboratory, Uppsala, Sweden.
  • Chen L; Department of Immunology, Genetics and Pathology, Uppsala University and Science for Life Laboratory, Rudbeck Laboratory, Uppsala, Sweden.
  • Essand M; Department of Immunology, Genetics and Pathology, Uppsala University and Science for Life Laboratory, Rudbeck Laboratory, Uppsala, Sweden.
  • Swartling FJ; Department of Immunology, Genetics and Pathology, Uppsala University and Science for Life Laboratory, Rudbeck Laboratory, Uppsala, Sweden.
  • Nelander S; Department of Immunology, Genetics and Pathology, Uppsala University and Science for Life Laboratory, Rudbeck Laboratory, Uppsala, Sweden.
  • Jiang Y; Department of Immunology, Genetics and Pathology, Uppsala University and Science for Life Laboratory, Rudbeck Laboratory, Uppsala, Sweden.
  • Uhrbom L; Department of Immunology, Genetics and Pathology, Uppsala University and Science for Life Laboratory, Rudbeck Laboratory, Uppsala, Sweden.
J Pathol ; 247(2): 228-240, 2019 02.
Article em En | MEDLINE | ID: mdl-30357839
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células-Tronco Neoplásicas / Neoplasias Encefálicas / Movimento Celular / Glioblastoma / Receptores Acoplados a Proteínas G / Proliferação de Células Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Pathol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Suécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células-Tronco Neoplásicas / Neoplasias Encefálicas / Movimento Celular / Glioblastoma / Receptores Acoplados a Proteínas G / Proliferação de Células Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Pathol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Suécia